A new digital eye screening programme designed to detect diabetic retinopathy, the leading cause of blindness in the developed world, has been launched. The Birmingham and Black Country Retinal Screening Programme is believed to be one of the largest retinal screening programmes in the world and will offer 90,000 diabetes patients access to an annual eye screen, with a digital photograph taken of the back of their eyes, at their high street optician or hospital clinic. The Screening Programme is using OptoMize iP, an innovative digital imaging software and electronic patient records system developed by Digital Healthcare, a Cambridge company that is the UK’s leading supplier of ophthalmology software.
